Nuvectra (NVTR) Form 3 Nuvectra / Jennifer Kosharek ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Kosharek Jennifer

(Last) (First) (Middle)

5830 GRANITE PARKWAY, 11TH FLOOR

(Street)

PLANO TX 75024

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/12/2018

3. Issuer Name and Ticker or Trading Symbol
Nuvectra Corp [ NVTR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Principal Accounting Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock(1)	2,486	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit(2)	07/07/2018	04/07/2019	Common Stock	697	0.0000	D
Restricted Stock Unit(3)	08/12/2018	05/12/2020	Common Stock	1,399	0.0000	D
Restricted Stock Unit(4)	08/12/2018	05/12/2020	Common Stock	2,123	0.0000	D
Restricted Stock Unit(5)	05/12/2019	05/12/2021	Common Stock	2,042	0.0000	D
Stock Option (right to buy)(6)	04/07/2017	04/08/2026	Common Stock	2,095	6.87	D
Stock Option (right to buy)(7)	05/12/2018	03/17/2027	Common Stock	2,100	6.35	D
Stock Option (right to buy)(8)	05/12/2018	04/10/2027	Common Stock	6,369	6.48	D
Stock Option (right to buy)(9)	05/12/2019	04/09/2028	Common Stock	4,083	13.47	D

Explanation of Responses:

1. Common stock received from the previous vesting of restricted stock unit grants.

2. Restricted stock units granted April 8, 2016. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Approximately one third vested April 7, 2017, and approximately one third vested in four approximately equal quarterly installments thereafter. The remaining one third balance is scheduled to vest in four approximately equal quarterly installments beginning July 7, 2018.

3. Restricted stock units granted March 17, 2017. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Approximately one third vested May 12, 2018. The remaining two thirds balance is scheduled to vest in eight approximately equal quarterly installments thereafter.

4. Restricted stock units granted April 10, 2017. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Approximately one third vested May 12, 2018. The remaining two thirds balance is scheduled to vest in eight approximately equal quarterly installments thereafter.

5. Restricted stock units granted April 9, 2018. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Approximately one third is scheduled to vest May 12, 2019. The remaining two thirds balance is scheduled to vest in eight approximately equal quarterly installments thereafter.

6. Stock options granted April 8, 2016. Approximately one third vested April 7, 2017, and approximately one third vested in four approximately equal quarterly installments thereafter. The remaining one third balance is scheduled to vest in four approximately equal quarterly installments beginning July 7, 2018.

7. Stock options granted March 17, 2017. Approximately one third vested May 12, 2018. The remaining two thirds balance is scheduled to vest in eight approximately equal quarterly installments thereafter.

8. Stock options granted April 10, 2017. Approximately one third vested May 12, 2018. The remaining two thirds balance is scheduled to vest in eight approximately equal quarterly installments thereafter.

9. Stock options granted April 9, 2018. Approximately one third is scheduled to vest May 12, 2019. The remaining two thirds balance is scheduled to vest in eight approximately equal quarterly installments thereafter.

	/s/ Melissa G Beare as attorney in fact for Jennifer Kosharek	06/13/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.